Matrix metalloproteinase pattern in celiac duodenal mucosa

Area of Science:

• Gastroenterology
• Immunology
• Biochemistry

Background:

• Matrix metalloproteinases (MMPs) are key enzymes in tissue remodeling.
• Their specific role in celiac disease (CD) pathogenesis is not well understood.
• Investigating MMPs in CD could reveal new insights into disease mechanisms.

Purpose of the Study:

• To quantify the expression and activity of various MMPs in celiac disease.
• To explore the relationship between MMPs and proinflammatory cytokines (IFN-gamma, TNF-alpha) in CD.
• To determine the cellular sources of MMPs in the celiac intestinal mucosa.

Main Methods:

• Analysis of duodenal biopsies from untreated celiac patients, treated celiac patients, and controls.
• Quantification of MMP-1, -2, -3, -9, -12, -14, TIMP-1, IFN-gamma, and TNF-alpha mRNA using RT-PCR.
• Assessment of MMP activities (gelatinolytic, caseinolytic, elastolytic) via gel zymography.
• Isolation and stimulation of lamina propria mononuclear cells (LPMCs) and myofibroblasts.

Main Results:

• MMP-1 and MMP-12 mRNA levels and associated activities were significantly elevated in active CD compared to treated patients and controls.
• MMP-12 levels correlated positively with IFN-gamma and the degree of villous atrophy.
• MMP-2 levels were significantly reduced in both untreated and treated celiac patients.
• TIMP-1 and IFN-gamma were upregulated in active CD, while TNF-alpha was suppressed.
• Cells from active CD patients constitutively expressed MMPs, unlike those from treated patients or controls.

Conclusions:

• Active celiac disease exhibits a distinct MMP profile, notably increased MMP-12, linked to IFN-gamma and mucosal damage.
• MMP-2 is downregulated in celiac disease, irrespective of treatment status.
• Cellular responses to cytokines differ between active and treated celiac disease, suggesting altered inflammatory signaling.